<?xml version="1.0" encoding="UTF-8"?>
<ref id="B350-viruses-12-00110">
 <label>350.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Caposio</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Musso</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Luganini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Inoue</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Gariglio</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Landolfo</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Gribaudo</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Targeting the NF-ÎºB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells</article-title>
  <source>Antivir. Res.</source>
  <year>2007</year>
  <volume>73</volume>
  <fpage>175</fpage>
  <lpage>184</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2006.10.001</pub-id>
  <?supplied-pmid 17070604?>
  <pub-id pub-id-type="pmid">17070604</pub-id>
 </element-citation>
</ref>
